Sino Biopharmaceutical Says TQB2102 Included In Breakthrough Therapeutic Designation Process In China

RefinitivMoins d'1 minute de lecture

Sino Biopharmaceutical Ltd 1177:

TQB2102 INCLUDED IN BREAKTHROUGH THERAPEUTIC DESIGNATION PROCESS IN CHINA

© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html

Connectez-vous ou créez un compte gratuit à vie pour lire ces nouvelles